Condition

Synovial Sarcomas clinical trials and research

• 8Clinical trials
• 6Countries

Newest Synovial Sarcomas clinical trials

All recruiting trials (8)

• TLN-499 plus venetoclax in relapsed or refractory solid tumors

  Doctors are testing whether TLN-499 added to venetoclax can help patients with relapsed or refractory solid tumors, including SCLC and certain neuroendocrine cancers.

  Recruiting Phase 1 Treeline Biosciences, Inc. · Camperdown, New South Wales and 2 other locations · NCT07713732

• ZI-MA4-1 cell therapy for hard-to-treat solid cancers

  This early-stage trial tests ZI-MA4-1, an allogeneic cell therapy, in patients with inoperable locally advanced or metastatic ovarian cancer, squamous NSCLC, synovial sarcoma, or head and neck cancer to see if it is safe and tolerable and to find a recommended dose.

  Recruiting at 2 sites Phase 1 Zelluna Immunotherapy AS · London and 1 other locations · NCT07613723

• Mipetresgene autoleucel (Mip-cel) for NY-ESO-1–positive synovial sarcoma

  This trial will test whether mipetresgene autoleucel (Mip-cel), a NY‑ESO‑1–targeted T‑cell therapy given after cyclophosphamide and fludarabine, can shrink tumors or control disease in adults with NY‑ESO‑1–positive synovial sarcoma.

  Recruiting at 3 sites Phase 3 Takara Bio Inc. · Osaka, Osaka and 2 other locations · NCT07174427

• Dose‑escalated, short‑course proton radiation for inoperable soft tissue sarcoma

  This will try higher-dose, shorter-course proton radiation to see if it controls tumors better in adults with inoperable soft tissue sarcoma.

  Recruiting Phase 2 Oslo University Hospital · Bergen and 1 other locations · NCT07173972

• Three-week preoperative proton versus X-ray radiotherapy for localized soft tissue sarcoma

  This trial tests whether selecting proton rather than standard X‑ray radiotherapy before surgery for adults with localized soft tissue sarcoma can lower long-term radiation side effects without increasing surgical complications.

  Recruiting Phase 2 Oslo University Hospital · Bergen and 3 other locations · NCT07169344

• Combining Lutathera® and Olaparib for treating recurrent solid tumors in children and adolescents

  This study is testing if combining Lutathera® with olaparib can help children and teenagers with hard-to-treat solid tumors that have certain receptors.

  Recruiting Phase 1/2 Fundación de investigación HM · Boadilla del Monte, Madrid · NCT06607692

• Zanzalintinib treatment for advanced leiomyosarcoma

  This study is testing if a new medication called zanzalintinib can help people with advanced leiomyosarcoma live longer without their cancer getting worse.

  Recruiting Phase 2 Northwestern University · Chicago, Illinois · NCT06571734

• Using AOH1996 to treat hard-to-treat solid tumors

  This study is testing a new drug called AOH1996 to see if it is safe and effective for people with hard-to-treat solid tumors like certain sarcomas and ovarian cancer.

  Recruiting at 2 sites Phase 1 City of Hope Medical Center · Scottsdale, Arizona and 2 other locations · NCT05227326

Related topics

Quick answers

How many Synovial Sarcomas clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in Norway (2 trials), United States (2 trials), Australia (1 trial), Japan (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 1: 3, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →